2017 American Transplant Congress

April 29-May 3, 2017 in Chicago, IL

View by Title View Sessions

View by Date

Jump to: View All • a [b] c d e f g h i j k l m n o p q r s t u v w x y z

B Cell Deficiency Inhibits Both Antibody Mediated Rejection and T Cell Mediated Acute Rejection in a Rat Kidney Transplant Model.

S. Panzer, S. Reese, N. Wilson Schlei, B. Verhoven, D. Xiang, W. Zhong, A. Djamali.
B Cell-Derived Cytokines Rather Than T/B Cognate Interactions Mediate CD8 T Cell Reconstitution Following Lymphoablation.

D. Zwick, K. Ayasoufi, R. Fan, V. Gorbacheva, K. Keslar, R. Fairchild, A. Valujskikh.
B Cells in Liver Transplant Tolerance.

M. Morita,¹ G. Asonye,¹ N. Gupta,¹ J. Fung,² C. Miller,³ S. Qian,^1,3 L. Lu.^1,3
Bacteremia in Kidney Transplant Recipients: Incidence, Risk Factors, and Outcomes.

S. Brar, Y. Wang, A. Cannitelli, Y. Li, O. Famure, S. Husain, J. Kim.
Banff 2013 Classification of Renal Allograft Pathology Is Superior to Banff 2007 in Detecting and Managing Milder and Earlier Cases of Antibody-Mediated Rejection.

J. Hassler,¹ V. Ariyamuthu,² A. Hendricks,¹ B. Tanriover,² J. Torrealba.¹
Bariatric Operations at a Service of the Transplant Surgery.

A. Keidar,¹ R. Yemini,¹ M. Ben David,¹ E. Nesher,² J. Vinkler,³ M. Broun,² E. Mor.²
Bariatric Surgery Prior to Living Kidney Donation: A Solution to Expand the Donor Pool.

M.-T. Nguyen, D. Carpenter, A. Mathur, J. Van Bever, R. Sandoval, L. Ratner.
Barriers and Experiences When Patients Decide on a Kidney Transplant Center.

C. Schaffhausen,^1,4 M. Bruin,³ J. Synder,^2,4 B. Kasiske,^1,4 A. Israni.^1,2,4
Barriers to Becoming Active on the Renal Transplant Waiting List: Have They Changed in the Last Five Years?

E. van Hardeveld,¹ T. Furlong,² A. Robertson,² N. Suh,² S. Thwaites,² R. Millar,² R. Masterson,¹ M. Lian,¹ B. Jones,¹ P. Hughes.¹
Baseline Immune Assessment to Individualize Immunosuppression in SPK Recipients with Type 1 Diabetes.

Y. Kudva, V. Dadlani, A. Miller, M. Abdallah, W. Kremers, M. Stegall, R. Abraham.
Belatacept After Kidney Transplantation in Adolescents.

C. Lerch, N. Kanzeleyer, T. Ahlenstiel-Grunow, K. Froede, M. Kreuzer, J. Drube, L. Pape.
Belatacept Conversion for Calcineurin Inhibitor (CNI) Toxicity: Our First 100 Patients.

R. Crew, S. Patel, A. Pai, I. Batal, H. Fernandez.
Belatacept Conversion in Kidney Recipients with Low GFR Does Not Improve Renal Function.

D. Abdelwahab,¹ S. Byron,² B. Kaplan,¹ R. Heilman.¹
Belatacept for Chronic Antibody-Mediated Rejection in Kidney Transplantation.

D. Kumar,¹ G. Gupta,¹ J. Reeve,² P. Sanghi,¹ S. Bobba,¹ M. Levy,¹ C. Bhati,¹ P. Kimball,¹ H. Fattah,¹ A. King,¹ H. Massey,¹ P. Halloran.²
Belatacept in Chronic Kidney Disease Stabilizes and Improves Renal Function in Pancreas Transplant Recipients: Intermediate Results.

J. Chen, M. Mujtaba, T. Taber, M. Yaqub, J. Powelson, O. Adebiyi, J. Fridell, A. Sharfuddin.
Beneficial Effects of Human Mesenchymal Stromal Cells on Porcine Hepatocytes Viability and Albumin Secretion.

E. Montanari,¹ J. Pimenta,¹ H.-J. Schuurman,¹ J. Meier,¹ R. Meyer,¹ A. Balaphas,¹ J. Sidibé,² A. Thomas,² S. Passemard,³ S. Gerber-Lemaire,³ C. Gonelle-Gispert,¹ L. Buhler.¹
Beneficial Effects of Hydrogen Sulfide (H2S) on Renal Ischemia-Reperfusion Injury (IRI) in CLAWN Miniature Swine.

Y. Ariyoshi, M. Sekijima, H. Sahara, T. Murokawa, A. Shimizu, K. Yamada.
Benefit of Anti-Hepatitis B Immunoglobulin(HBIG) Monotherapy Compared to HBIG Combined with Entecavir in Long Term Renal Function.

J. Lee,¹ J. Lee,¹ J. Lee,² S. Song,¹ J. Lee,¹ S.-K. Kwon,¹ M. Kim,¹ G. Choi,¹ S. Kim,¹ D. Joo.¹
Benefits of Expanding Options for Patients Registered in the Kidney Paired Donation Program.

S. Stepkowski, B. Mierzejewska, D. Belbolsynov, C. Baum, J. Kopke, R. Brunner, S. Rees, M. Rees.
Benefits of Induction in Recipients of Acute Renal Failure Donor Kidneys.

M. Barrett, A. Smith, K. Woodside, R. Sung.
Benefits of Multimodal Enhanced Recovery Pathway in Patients Undergoing Kidney Transplantation.

K. Espino,¹ L. Kayler.²
Benefits of Mycophenolate Sodium Over Mycophenolate Mofetil in Renal Transplant Patients Carrying UGT1A9 Polymorphism.

N. Calvo Romero, I. Perez-Flores, A. Shabaka, M. Moreno De La Higuera, B. Rodriguez-Cubillo, J. Delgado, M. Calvo, V. Lopez De La Manzanara, A. Sanchez-Fructuoso.
Beta Cell-Specific Free Circulating DNA May Predict the Outcome After Clinical Islet Transplantation.

B. Gala-Lopez,¹ D. Neiman,² T. Kin,¹ D. O'Gorman,¹ A. Pepper,¹ A. Malcolm,¹ B. Glaser,³ R. Shemer,² Y. Dor,² J. Shapiro.¹
Beyond the Bones – The Association Between Vitamin D, Graft Outcomes, Malignancy and Vascular Disease.

A. Seitz,¹ A. Cherukuri,² R. Baker.¹
Biliary Complications After Pediatric Liver Transplantation: A High Volume Living Donor Liver Transplantation Center Study of 237 Patients Over 27 Years.

D. Oh,¹ N.-J. Yi,¹ S. Ahn,¹ S. Hong,¹ K. Yoon,¹ H.-S. Kim,¹ H. Kim,¹ K.-W. Lee,¹ K.-S. Suh,¹ J. Han,² M. Kim,² J. Lee.²
Biliary Complications Following Liver Transplantation – Single-Center Experience Over Three Decades and Recent Risk Factors.

A. Kaltenborn, A. Gutcke, H. Schrem, J. Gwiasda.
Biliary Complications in Pediatric Liver Transplantation for Cystic Fibrosis: A Single-Center Experience with Choledochocholedochostomy.

P. Rizk, J. Moffett, M. Vu, R. Ackah, R. Sigireddi, M. Finegold, C. O'Mahony, A. Rana, J. Goss.
Binding of Antigens by Its Specific Antibodies Results in Exosome Formation Leading to Rejection of Syngeneic Murine Cardiac Grafts.

M. Sharma, W. Liu, M. Gunasekaran, S. Bansal, T. Mohanakumar.
Binding of Human Neutrophils to Activated Porcine Endothelium Is Mediated by E-Selectin.

C. Laird,¹ B. French,¹ L. Burdorf,¹ X. Cheng,¹ W. Fogler,² J. Magnani,² C. Phelps,³ D. Ayares,³ A. Azimzadeh,¹ R. Pierson.¹
Biodistribution of Adipose Derived Regenerative Cells Administered via the Renal Artery in Novel Rat Transplant Model.

R. Ghita,^1,2 R. Lathan,² D. Hillyard,² P. Mark,^1,2 M. Clancy.^1,2
Bioengineering Human Islets to Form Peri-Islet Vessels from Intraislet Endothelial Cells for Improving Human Islet Function.

G. Loganathan, S. Narayanan, M. Dhanasekaran, A. Patel, W. Tucker, M. Hughes, S. Williams, A. Balamurugan.
Biological Interplay Between Circulating HLA-sp Alloreactive Memory B-Cells and Long-Lived Plasma Cells in Kidney Transplant Patients Undergoing Chronic ABMR.

S. Luque,² M. Lúcia,⁴ M. Jarque,² E. Crespo,² E. Melilli,¹ J. Martorell,³ J. Cruzado,^1,2 J. Torras,^1,2 J. Grinyó,^1,2 O. Bestard.^1,2
Biomarkers of Epithelial-Mesenchymal Transition (EMT) in Chronic Allograft Nephropathy: Potential for Early Detection and Development of Novel Therapeutic Agents.

S. Kanangat, R. Miller, S. Rezaeian, H. Eldib, D. Cimbaluk, C. Fhied, I. Kurbegovic-Skaljic, M. Prod, J. Borgia, M. Flaws, D. Castillo, R. DeCresce.
Biopsies (Bx) of Renal Allografts with Antibody- + Cell-Mediated Rejection (ABMR/CMR) Exhibit Gene Expression Signatures from Both Types of Rejection.

H. Zhang,¹ C. Nast,² J. Doldron,² M. Cheung,² J. Mirocha,³ J. Kahwaji,¹ A. Vo,¹ S. Jordan,¹ M. Toyoda.¹
BK Polyoma Virus and Malignancy: Cause or Co-Incidence?

R. Prashar, A. Shah, D. Stewart, S. Williamson, A. Patel.
BK Polyomavirus-Specific 9mer T-Cell Responses Predict Control of Viremia in Kidney Transplant Recipients: First Report from the Swiss Transplant Cohort Study.

H. Hirsch,¹ C. Leboeuf,¹ S. Wilk,¹ R. Achermann,² I. Binet,³ D. Golshayan,² K. Hadaya,² C. Hirzel,² M. Hoffmann,² U. Huynh-Do,² M. Koller,² O. Manuel,² N. Mueller,² T. Mueller,² S. Schaub,² C. Van Delden,² F. Weissbach.¹
BK Viruria Levels within 3 Months Post Renal Transplantation Can Predict the Development of BK Viraemia.

N. Lioufas,¹ R. Masterson,^1,2 P. Hughes.
BK Virus in Simultaneous Pancreas Kidney Transplantation.

P. Uva,^1,2 L. Leon,¹ E. Minue,¹ A. Dotta,¹ F. Toniolo,¹ R. Pilotti,¹ E. Chuluyan,² D. Casadei.¹
BK Virus Infection and Risk of Urinary Tract Cancers Among Kidney Transplant Patients in the Transplant Cancer Match Study.

G. Gupta,¹ S. Kuppachi,² R. Kalil,² C. Buck,³ C. Lynch,² E. Engels.³
BK Virus, Cytomegalovirus and Epstein-Barr Virus Reactivation in Renal Transplant Patients: Results from a Large Multicenter Study.

A. Blázquez-Navarro,¹ C. Dang-Heine,¹ M. Or-Guil,² C. Bauer,³ T. Westoff,⁴ C. Hugo,⁵ P. Reinke,¹ B. Sawitzki,¹ N. Babel.^1,4
BKV Clearance Time Correlates with T-Cell Receptor Repertoire Shape and Exhaustion State of BKV-Specific T-Cells in Renal Transplant Patients with Severe BKV Infection.

U. Stervbo,^1,2 M. Nienen,¹ B. Weist,² P. Wehler,² T. Westhoff,¹ H.-D. Volk,² P. Reinke,² N. Babel.^1,2
Blockade of Tim-3 and PD-1 Reverses Dysfunctions of Tumor Infiltrating Lymphocytes in HBV Related Hepatocellular Carcinoma.

A. Hu, F. Liu, X. Zhu, X. He.
Blocked of Bat3 Expression Promotes Transplant Tolerance by Inducing IL-10 Expression in Dendritic Cells.

G. Gu, H. Hang, Q. Xia.
Blood and Biopsy Genomic Signatures of Acute Rejection in Liver Transplant Recipients.

J. Levitsky,¹ T. Whisenant,² S. Kurian,² S. Rao,¹ A. Demetris,³ M. Abecassis.¹
Blood Gene Expression Predicts Bronchiolitis Obliterans Syndrome Appearance After Lung Transplantation.

R. Danger,¹ P. Royer,² D. Reboulleau,² J. Loy,² A. Tissot,² P. Lacoste,² A. Roux,³ M. Reynaud-Gaubert,⁴ R. Kessler,⁵ S. Mussot,⁶ C. Dromer,⁷ O. Brugière,⁸ J. Mornex,⁹ R. Guillemain,¹⁰ M. Dahan,¹¹ C. Knoop,¹² K. Botturi,² C. Pison,¹³ L. Nicod,¹⁴ S. Brouard,¹ A. Magnan,² COLT and SysCLAD Consortia.
Blood Tfh Cells Exhibit Impaired B Cell Help in Operationally Tolerant Patients.

R. Danger,¹ A. Chenouard,¹ M. Chesneau,¹ S. Castagnet,² P. Guérif,¹ N. Degauque,¹ M. Giral,¹ S. Brouard.¹
Blood Transfusion Before Organ Transplant: Patient Sensitization and Outcomes.

I. Cich, K. Rudser, R. Brown, H. Ibrahim, R. Thorson, J. Patil, G. Loor, M. Hertz, C. Cohn.
Blood Transfusion Induced Donor Specific Antibodies Are Associated with Rejection and Graft Failure.

S. Hassan,¹ F. Regan,^2,3 C. Brown,⁴ A. Harmer,³ N. Anderson,³ P. Brookes,⁵ D. Taube,¹ M. Willicombe.¹
Bortezomib for Late Antibody-Mediated Rejection After Renal Transplantation: A Single Center Experience of 22 Cases.

J. Choi, J. Jung, S. Chun, S. Shin, Y. Kim, D. Han.
Brain-Dead Donors Terminal Inflammation Is Associated to Delayed Graft Function in Kidney Transplant Recipients.

D. Cucchiari,¹ D. Fritz,² V. Pedro,² A. Ramon,³ P. David,³ R. Jordi,² O. Frederic,² R. Ignacio.²
Building a Conceptual Framework of Treatment Burden After Kidney Transplant: A Qualitative Study.

E. Lorenz, J. Egginton, M. Stegall, A. Cheville, D. Eton.
Burden of Early Hospitalization Among Liver Transplant Recipients.

P. Sharma,¹ N. Goodrich,³ D. Schaubel,² A. Smith,³ R. Merion.^3,4

Jump to: View All • a [b] c d e f g h i j k l m n o p q r s t u v w x y z